- Home >
- Life Sciences >
- Pharmaceutical >
Pharmaceutical Industry Analysis and Statistics (since 2008 - p40)
Refine results by
Top countries
Publication dates
- All
- Since 2009 (5 630)
- Since 2008
All countries
Popular tags
All premium reports for Pharmaceutical Industry Analysis and Statistics (since 2008 - p40)
1171-1200 of 6 467 Premium Reports from 56 Publishers
Moldova Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
Moldova?s pharmaceutical market stood at US$206mn in 2008 and is forecast to grow to US$309mn in2013. This represents a compound annual growth rate (CAGR) of 14.08%. The country has seen itshealthcare budget almost triple since the introduction of obligatory health insurance in 2003, and in thecomin ...
Industries : Healthcare, Pharmaceutical
Morocco Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
For this Q209 Morocco Pharmaceuticals and Healthcare Report, BMI has forecast the total drug marketwill increase in value from US$1.38bn in 2008 to US$1.74bn by 2013, representing a compound annualgrowth rate of 4.75% in US dollar terms. The prescription pharmaceuticals will fall to reach 63.9%propo ...
Industries : Healthcare, Pharmaceutical
Qatar Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
In BMI?s Q209 Business Environment rankings for the Middle East and Africa, Qatar remains placedsecond out of 17 countries in the region, below only the much more populous United Arab Emirates(UAE). Qatar?s ranking demonstrates its favourable country structure, which includes a high level ofurbanisa ...
Industries : Healthcare, Pharmaceutical
South Africa Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
In BMI?s Business Environment Ratings for Q209, South Africa?s position continued to worsen, with thecountry slipping from sixth to seventh position of the 17 Middle East and Africa (MEA) marketssurveyed. Key reasons behind this slide include the strict pricing and reimbursement regime, as well asth ...
Industries : Healthcare, Pharmaceutical
Switzerland Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
The Swiss pharmaceutical market witnessed a minor slowdown in 2008, with data released from industryassociation Interpharma showing sales increasing by 5.3% versus 2007. Reduced growth levels havebeen attributed to widespread price cuts in March 2008, which shaved an estimated CHF93mn(US$77mn) off t ...
Industries : Healthcare, Pharmaceutical
Turkey Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
Outside the BRIC (Brazil, Russia, India, China) states, Turkey is considered one of the key growthpharmaceutical markets globally. Growth has been rapid in recent years, with per capita spendingreaching US$159 in 2008, a similar level to other emerging countries in Eastern Europe. The country?slarge ...
Industries : Healthcare, Pharmaceutical
Vietnam Pharmaceuticals and Healthcare Report Q2 2009
- $ 495
- April 2009
In 2008, Vietnam?s drug market was worth around VND19.8bn (US$1.2bn). By the end of 2013, BMIforecasts that drug expenditure should reach VND35.3bn (US$2bn), representing a compound annualgrowth rate (CAGR) of 10.9% between 2008 and 2013. In light of the worsening global economicclimate, we have rev ...
Industries : Healthcare, Pharmaceutical
Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Canada neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and com ...
Industries : Medical Devices, Therapy
Medicinal and Pharmaceutical Products Manufacturing in Indonesia
- $ 518
- April 2009
This report consists of establishments mainly engaged in manufacturing drugs, medicinal chemicals or other pharmaceutical products, except herbal medicine, for human or veterinary use. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and suc ...
Industries : Pharmaceutical
Medicinal and Pharmaceutical Products Manufacturing in Indonesia
- $ 496
- April 2009
This report consists of establishments mainly engaged in manufacturing drugs, medicinal chemicals or other pharmaceutical products, except herbal medicine, for human or veterinary use. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and suc ...
Industries : General Medicine and Specialty Medicine, Pharmaceutical
China Cardiovascular Devices Market Analysis & Forecasts to 2015
- $ 3 500
- April 2009
China Cardiovascular Devices Market Analysis & Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to the China cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company sha ...
Industries : Pathology
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015
- $ 3 500
- April 2009
Germany Diabetes Care Devices Market Analysis & Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to the Germany diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company sh ...
Industries : Pharmaceutical
United States Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
United States Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to United States neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distri ...
Industries : Medical Devices, Therapy
United Kingdom Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
United Kingdom Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to UK neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and ...
Industries : Medical Devices, Therapy
World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments
- $ 750
- April 2009
Report DetailsWorld Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments published by Renub Research talks about the world vaccine market. This report gives the past, present scenario on the vaccines market and also forecast on future of vaccines market. Such as market size o ...
Industries : Pharmaceutical
Practical Guide to Finding Partners in Pharma and Biotech
- $ 1 011
- April 2009
CurrentPartnering?s Practical Guide to Finding Partners in Biopharma provides a comprehensive overview of all the steps required to identify and secure partnering either for an in-licensing or out-licensing activity.The report takes the reader through the practical steps required to prepare for part ...
Industries : Biotechnology, Pharmaceutical
Research Report on Chinese Chemical Pharmaceuticals Industry, 2009
- $ 1 450
- April 2009
The chemical pharmaceuticals industry is the largest sub-sector of Chinese pharmaceuticals industry. In 2008, the sales revenues of Chinese chemical raw material medicines were 26.5 billion USD and the sales revenues of the chemical preparation industry were 3.34 billion USD, with the average growth ...
Industries : Pharmaceutical
Stakeholder Opinions: Urinary Tract Infections Growing resistance rates bring opportunities for both new and old drugs
- $ 5 795
- April 2009
IntroductionUrinary tract infections (UTIs) include infections of the kidneys, ureters, and bladder. Escherichia coli is the major UTI pathogen, with emerging extended-spectrum beta-lactamase (ESBL)-producing strains proving particularly difficult to treat. Bacterial resistance to the most commonly ...
Industries : Pathology
Stakeholder Opinions: Renal Anemia Early diagnosis and management of anemia: reducing costs and improving the outcomes in chronic kidney disease
- $ 8 195
- April 2009
IntroductionThe diagnosis of renal anemia is routinely performed and relatively straightforward, while treatment with highly effective erythropoietin-stimulating agents is widely available in all major markets. However, the extremely high cost of treatment prevents many healthcare providers from del ...
Industries : Pharmaceutical
Belgium Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
BMI calculates Belgium?s pharmaceutical expenditure to have been EUR4.08bn (US$5.61bn) in 2008.By 2013, we expect the total amount spent on prescription and over-the-counter (OTC) medicines to havereached a value of EUR4.42bn equating to a compound annual growth rate (CAGR) of 1.8%. In US dollarterm ...
Industries : Pharmaceutical
Bulgaria Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
The Bulgarian pharmaceutical market, like many others, underwent significant reform before, during andafter EU accession. While the country remains one of the least developed in the EU both economicallyand in terms of healthcare, market reform looks set to boost patient access to medicines as well a ...
Industries : Pharmaceutical
Colombia Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
In BMI?s updated Business Environment Ranking table for the Americas, Colombia?s score has remainedthe same, again ranking the country fifth out of the 10 major markets in the region. While the risingpopulation numbers and a steady forecast market growth represent considerable draws for foreigncompa ...
Industries : Pharmaceutical
Czech Republic Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
BMI forecasts that the Czech drug market will grow at a compound annual growth rate (CAGR) of 4.8%over the 2008-2013 period. Although this represents a fall on the 8.1% growth and 13.9% growthwitnessed in 2008 and 2007 respectively, it is indeed encouraging in light of the economic turmoil inwhich m ...
Industries : Pharmaceutical
Egypt Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
For this Q209 Pharmaceutical and Healthcare Report for Egypt, BMI forecasts that drug spending willincrease from US$2.34bn in 2008 to US$4.10bn by 2013, representing a compound annual growth rate(CAGR) of 11.8% over the five year period. We believe the main drivers for growth will be the expectedhea ...
Industries : Pharmaceutical
Indonesia Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
Indonesia is one of the most promising long-term opportunities for pharmaceutical companies. However,numerous short-term challenges must be overcome, such as protectionist government and inequitableaccess to healthcare. The value of pharmaceuticals sold in 2008 reached US$2.79bn and BMI isforecastin ...
Industries : Pharmaceutical
Italy Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
Italian economy is one of the most vulnerable economies in an already shaky eurozone. High public debt,poor infrastructure, and a lack of competitiveness are the basis for the likelihood that the country willremain on the region's laggards over our forecast period. Additionally, low levels of growth ...
Industries : Pharmaceutical
Nigeria Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
For this Q209 Pharmaceutical and Healthcare Nigeria report, BMI has forecast that the total drug marketwill increase from US$633mn in 2008 to US$695mn by 2013, representing a compound annual growthrate (CAGR) of 1.89% in US dollar terms and 3.24% with respect to the Nigerian naira. We believe themai ...
Industries : Pharmaceutical
Pakistan Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
The value of Pakistan?s pharmaceutical market is forecast to reach US$3.34bn by 2013, representing acompound annual growth rate (CAGR) of 10.55%. This rate of expansion is one of the highest in ourcoverage universe. However, it is at significant risk due to the escalation of political unrest and te ...
Industries : Pharmaceutical
Peru Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
In BMI?s updated Business Environment Rankings (BER) for Q209, Peru remained second-bottom in thematrix assessing ten major markets in the Americas. A small market size and a deficient intellectualproperty (IP) environment ? including the tolerance for non-bioequivalent similares and widespreadcount ...
Industries : Pharmaceutical
Poland Pharmaceuticals Report Q2 2009
- $ 495
- April 2009
Top line data for pharmaceutical sales in Poland suggest that the market holds significant potential fordrugmakers. Healthy levels of growth, coupled with an already substantial market size, saw per capitaspending rise to US$215 in 2008. Through to 2013, sales of pharmaceuticals, which include presc ...
Industries : Pharmaceutical
reportlinker.com © Copyright 2009. All rights reserved